1. V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma
- Author
-
Walter M Gregory, Annemiek Broijl, Pieter Sonneveld, Rebecca Wijers, Reno Debets, Sonja Zweegman, Dora Hammerl, Bronno van der Holt, Rowan Kuiper, Hayri E. Balcioglu, Pim G.N.J. Mutsaers, Mark van Duin, Hematology, Medical Oncology, AII - Cancer immunology, CCA - Cancer biology and immunology, and Anatomy and neurosciences
- Subjects
0301 basic medicine ,Cancer Research ,Stromal cell ,T cell ,Article ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Immunity ,immune therapy ,V-domain Ig suppressor of T cell activation (VISTA) ,Medicine ,tumor immunology ,Multiple myeloma ,RC254-282 ,biology ,business.industry ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,immune checkpoints ,medicine.disease ,multiple myeloma ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,biology.protein ,Cancer research ,Bone marrow ,Antibody ,business ,V-domain Ig suppressor of T cell activation (VISTA), immune checkpoints ,CD8 - Abstract
Multiple myeloma (MM) is characterized by loss of anti-tumor T cell immunity. Despite moderate success of treatment with anti-PD1 antibodies, effective treatment is still challenged by poor T cell-mediated control of MM. To better enable identification of shortcomings in T-cell immunity that relate to overall survival (OS), we interrogated transcriptomic data of bone marrow samples from eight clinical trials (n = 1654) and one trial-independent patient cohort (n = 718) for multivariate analysis. Gene expression of V-domain Ig suppressor of T cell activation (VISTA) was observed to correlate to OS [hazard ratio (HR): 0.72, 95% CI: 0.61–0.83, p = 0.005]. Upon imaging the immune contexture of MM bone marrow tissues (n = 22) via multiplex in situ stainings, we demonstrated that VISTA was expressed predominantly by CD11b+ myeloid cells. The combination of abundance of VISTA+, CD11b+ cells in the tumor but not stromal tissue together with low presence of CD8+ T cells in the same tissue compartment, termed a high VISTA-associated T cell exclusion score, was significantly associated with short OS [HR: 16.6, 95% CI: 4.54–62.50, p <, 0.0001]. Taken together, the prognostic value of a combined score of VISTA+, CD11b+ and CD8+ cells in the tumor compartment could potentially be utilized to guide stratification of MM patients for immune therapies.
- Published
- 2021
- Full Text
- View/download PDF